Skip to content

PharMerica CORP

CIK 0001388195

← back to feed
Revenue (TTM)
$2.27B
+4.3% YoY Q3 Nov 2017
Net Income (TTM)
$18.7M
+5.5% YoY Q3 Nov 2017
EPS Diluted (TTM)
$0.59
+8.7% YoY Q3 Nov 2017
Gross Margin
15.2%
Q3 Nov 2017
Operating Margin
1.9%
Q3 Nov 2017
Net Margin
0.8%
Q3 Nov 2017
Free Cash Flow (TTM)
$39.1M
Q3 Nov 2017
Cash
$7.8M
Q3 Nov 2017
Total Debt
$460.2M
Q3 Nov 2017
Shares Outstanding
31.12M sh
Q3 Nov 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings